Board Communique to members and consumer reps
As 2023 draws to a close, we are distributing a Board Communique from our Chair Tony Lawson.
Board Communique to members and consumer reps
As 2023 draws to a close, we are distributing a Board Communique from our Chair Tony Lawson.
The COVID-19 Response Inquiry is currently being led by the Department of the Prime Minister and Cabinet (PM&C). The inquiry is collecting evidence and policy recommendations on Australia's health and non-health response to the COVID-19 pandemic. The final aim of the inquiry is to ...
Pharmacists in 2030 is a consultation being undertaken by the Pharmaceutical Society of Australia (PSA) and is will build on their 2019 report: Pharmacists in 2023. The report will map out how the pharmacy sector can play...
In this edition of Consumer Voices we:
...
CHF engaged in a wide range of policy discussions reflecting our desire (supported by the Australian government) to put consumers at the centre of the discussion and ensure their voices were heard.
During 2022–23 we focussed on advocacy efforts in the following areas:
CHF engaged in a wide range of policy discussions reflecting our desire (supported by the Australian government) to put consumers at the centre of the discussion and ensure their voices were heard.
During 2022–23 we focussed on advocacy efforts in the following areas:
In this edition of Consumer Voices we:
...
In this edition of Consumer Voices we:
This year has set CHF on an exciting trajectory as we work towards achieving safe, good quality, timely healthcare for all Australians, supported by the best health information and systems the country can afford.
Securing sustainable funding in May 2023 was the result of an effective pre-...
In this edition of Consumer Voices we:
Our monthly newsletter Consumer Voices will keep up to date with our activities and opportunities for you to be involved and have your say. You can choose to hear from us about new opportunities, events, webinars and more.
Get updates from CHF